Caio Max S Rocha Lima
NRG Oncology · University of Miami Sylvester Comprehensive Cancer Center · University of Miami
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Caio Max S Rocha Lima as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:32 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT02997228 · Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT StudyNational Cancer Institute (NCI) · active not recruiting · Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v7 · principal investigator
- Ph2NCT00691054 · Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine TherapyUniversity of Miami · completed · Pancreatic Cancer · study chair
- N/ANCT00448838 · Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerUniversity of Miami · completed · Pancreatic Cancer · study chair
- Ph2NCT00305786 · Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerUniversity of Miami · completed · Lung Cancer · study chair
- Ph2NCT00290693 · Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic CancerUniversity of Miami · completed · Pancreatic Cancer · principal investigator
- Ph2NCT00276861 · Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon CancerUniversity of Miami · terminated · Colorectal Cancer · study chair
- Ph2NCT00004139 · Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerAlliance for Clinical Trials in Oncology · completed · Lung Cancer · study chair
- Ph2NCT00059982 · Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic CancerEastern Cooperative Oncology Group · completed · Pancreatic Cancer · unknown
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:32 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- NRG Oncology Network Group Operations CenterU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Quynh-Thu Xuan Le, ROBERT S. MANNEL, NORMAN WOLMARK · fiscal years 2014 to 2026Named on NCT02997228
- Cancer and Leukemia Group BU10CA031946 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Monica M Bertagnolli · fiscal years 1985 to 2013Named on NCT00004139
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in colorectal cancer.